MapLight Therapeutics, Inc.
MPLT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $701 | $556 | $574 |
| Gross Profit | -$701 | -$556 | -$574 |
| % Margin | – | – | – |
| R&D Expenses | $67,822 | $49,119 | $26,570 |
| G&A Expenses | $0 | $0 | $0 |
| SG&A Expenses | $14,423 | $7,607 | $4,101 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $82,245 | $56,726 | $30,671 |
| Operating Income | -$82,946 | -$57,282 | -$31,245 |
| % Margin | – | – | – |
| Other Income/Exp. Net | $5,366 | $1,573 | $1,229 |
| Pre-Tax Income | -$77,580 | -$55,709 | -$30,016 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$77,580 | -$55,709 | -$30,016 |
| % Margin | – | – | – |
| EPS | -1.87 | -1.34 | -0.72 |
| % Growth | -39.6% | -86.1% | – |
| EPS Diluted | -1.87 | -1.34 | -0.72 |
| Weighted Avg Shares Out | 41,429 | 41,429 | 41,429 |
| Weighted Avg Shares Out Dil | 41,429 | 41,429 | 41,429 |
| Supplemental Information | – | – | – |
| Interest Income | $4,504 | $1,099 | $429 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $701 | $556 | $574 |
| EBITDA | -$76,879 | -$55,153 | -$29,442 |
| % Margin | – | – | – |